Stock Mumak

Stock Profile

AstraZeneca PLC

AstraZeneca is one of the world's leading pharmaceutical companies. Growth, strong cash flows, and an innovative drug pipeline support long-term prospects.

Stock Snapshot

AstraZeneca Logo
Table HeaderTable Header
CompanyAstraZeneca PLC
SectorPharmaceuticals & Biotechnology
ThemeOncology, prescription drugs
Business ModelDevelopment and production of prescription drugs, primarily for oncology, cardiovascular, and metabolic diseases
ISINGB0009895292
Market Capitalizationapprox. €285 billion
UMBRELLA StatusWatchlist

Price Performance (12 Months)

Latest Portfolio Updates

Weekly Update

Weekly Market Overview – November 2–November 8, 2026

A massive sell-off in US markets, exceptional quarterly results in healthcare, and extensive risk reductions: the UMBRELLA strategy responds to
Company Update

Revolution Medicines – Q3 2026 Earnings Update

RASONQUE launch brings first revenues, research expenses remain high.
Company Update

Rheinmetall – Q3 2026 Earnings Update

Strong Q3 2026, stock under pressure after guidance cut.
Strategy in Action

Bayer – Position further expanded

The UMBRELLA strategy continues to expand its Bayer position. Positive price momentum, progress in the pharmaceutical business, and an improved
All Portfolio Updates

Termine & Ereignisse

DatumEreignisDetails
19. Nov. 2026 Quartalszahlen Q3 2026 Umsatz, Margen und Ausblick
10. Dez. 2026 Investorentag Strategie und Unternehmensentwicklung
20. Aug. 2026 Quartalszahlen Q2 2026 Ergebnisse und Geschäftsverlauf
15. Mai 2026 Quartalszahlen Q1 2026 Umsatz und Ergebnisentwicklung

Aktuelle Unternehmensmeldungen